Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: A case series and review

Journal of Dermatological Treatment

Volumn 22, Issue 6, 2011, Pages 353-358

  Lacarrubba, Francesco ^a   Potenza, Maria Concetta ^b   Gurgone, Silvia ^a   Micali, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Basal cell carcinoma; Imiquimod; Topical therapy

Indexed keywords

IMIQUIMOD;

ADULT; AGED; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER SIZE; CASE REPORT; DISEASE SEVERITY; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; EPILUMINESCENCE MICROSCOPY; ERYTHEMA; FEMALE; FOOD AND DRUG ADMINISTRATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PUNCH BIOPSY; REVIEW; SKIN PRURITUS; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; CARCINOMA, BASAL CELL; EMOLLIENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; SAMPLING STUDIES; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80855150733     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2010.548503     Document Type: Review

References (16)

1. Micali G, Lacarrubba F, Dinotta F, Massimino D, Nasca MR. Treating skin cancer with topical cream. Expert Opin Pharmacother. 2010;11:1515-1527.
2. Drehs MM, Cook-Bolden F, Tanzi EL, Weinberg JM. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: Case report and review of the literature. Dermatol Surg. 2002;28:427-429. (Pubitemid 34596305)
3. Berman B, Sullivan T, De Araujo T, Nadji M. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle. Br J Dermatol. 2003;66: 59-61. (Pubitemid 38064522)
4. Chen TM, Rosen T, Orengo I. Treatment of a large superficial basal cell carcinoma with 5% imiquimod: A case report and review of the literature. Dermatol Surg. 2002;28: 344-346. (Pubitemid 34461431)
5. Shumack S, Gebauer K, Quirk C, Macdonald K, Walters SA, Owens M. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Arch Dermatol. 2004;140: 1286-1287. (Pubitemid 39362257)
6. Micali M, Nasca MR, Musumeci ML. Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream. Int J Tissue React. 2005;27: 111-114. (Pubitemid 41723727)
7. Malhotra AK, Bansal A, Mridha AR, Khaitan BK, Verma KK. Superficial basal cell carcinoma on face treated with 5% imiquimod cream. Indian J Dermatol Venereol Leprol. 2006;72:373-375. (Pubitemid 44579170)
8. Mehta V, Balachandran C. Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream. Indian J Dermatol. 2008;53:140-141.
9. Schiessl C, Wolber C, Tauber M, Offner F, Strohal R. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow- up. J Drugs Dermatol. 2007;6:507-513.
10. Shulstad RM. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma. Dermatol Nurs. 2009;21:86-87.
11. Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol. 2004;50:722-733. (Pubitemid 38580549)
12. Geisse JK, Rich P, Pandya A, Gross K, Andres K, Ginkel A, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol. 2002;47: 390-398.
13. Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrándiz C, Garcia Diez A, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol. 2005;152:939-947. (Pubitemid 40704934)
14. Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: Randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol. 2002;147:1227-1236. (Pubitemid 36963032)
15. Eigentler TK, Kamin A, Weide BM, Breuninger H, Caroli UM, Möhrle M, et al. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol. 2007;57:616-621. (Pubitemid 47384927)
16. Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Fox TL, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial. Australasian Multicentre Trial Group. J Am Acad Dermatol. 2001;44:807-813. (Pubitemid 32391169)